Combination therapy of botensilimab (BOT) plus balstilimab (BAL) was approved Monday as an updated national treatment protocol for patients with certain ovarian cancers and soft tissue sarcomas (STS) ...
Project LiBRha aims to improve pediatric STS diagnosis and treatment through comprehensive molecular testing and liquid biopsy integration. The initiative involves 18 centers and partnerships with the ...
10hon MSN
2-Year-Old Boy Diagnosed with Rare Cancer After His Mom Noticed Him Turning 'Blue' in the Bathtub
"We sat him on the bed and knew that something wasn't right," Louisa Shilleto said of her 2-year-old son, Charlie ...
A model famous around the world for her provocative snaps has tragically died days after retiring. Japanese model Aoi Fujino ...
A world famous swimsuit model has died at just 27 years old after cryptically asking fans to 'remember me'. Japanese model ...
A swimsuit model's mum has confirmed her daughter's death at the age of 27 just days after she had revealed she was stepping ...
Annamycin consistently demonstrates no evidence of cardiotoxicity across five clinical trials – This next-generation ...
First MIRACLE trial unblinding expected Q1 2026; Global trial now spans nine countries – Investigator-Initiated (IIT) funded ...
Annamycin consistently demonstrates no evidence of cardiotoxicity across five clinical trials - This next-generation anthracycline demonstrates safety and promising early activity in treating multiple ...
Intensity Therapeutics, Inc. ("Intensity" or "the Company"), a late-stage clinical biotechnology company focused on the ...
Peer-reviewed clinical validation, strengthened balance sheet, and disciplined execution position the Company for 2026 SHELTON, Conn., Jan. 13, 2026 /PRNewswire/ -- ...
Detailed price information for Moleculin Biotech CS (MBRX-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback